NYSE:NUS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. More Details


Snowflake Analysis

Established dividend payer with adequate balance sheet.


Similar Companies

Share Price & News

How has Nu Skin Enterprises's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NUS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-0.5%

NUS

2.3%

US Personal Products

-1.1%

US Market


1 Year Return

19.8%

NUS

7.3%

US Personal Products

15.6%

US Market

Return vs Industry: NUS exceeded the US Personal Products industry which returned 11% over the past year.

Return vs Market: NUS exceeded the US Market which returned 17.8% over the past year.


Shareholder returns

NUSIndustryMarket
7 Day-0.5%2.3%-1.1%
30 Day5.4%6.0%4.2%
90 Day23.6%17.3%6.3%
1 Year25.0%19.8%8.4%7.3%18.2%15.6%
3 Year-6.9%-14.9%56.1%49.5%39.6%30.4%
5 Year57.5%34.8%61.1%47.6%79.5%59.2%

Price Volatility Vs. Market

How volatile is Nu Skin Enterprises's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nu Skin Enterprises undervalued compared to its fair value and its price relative to the market?

20.06x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: NUS ($53.64) is trading above our estimate of fair value ($44.6)

Significantly Below Fair Value: NUS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: NUS is poor value based on its PE Ratio (20.1x) compared to the US Personal Products industry average (19.3x).

PE vs Market: NUS is poor value based on its PE Ratio (20.1x) compared to the US market (19.1x).


Price to Earnings Growth Ratio

PEG Ratio: NUS is poor value based on its PEG Ratio (1.6x)


Price to Book Ratio

PB vs Industry: NUS is overvalued based on its PB Ratio (3.5x) compared to the US Personal Products industry average (1.5x).


Next Steps

Future Growth

How is Nu Skin Enterprises forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

12.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NUS's forecast earnings growth (12.9% per year) is above the savings rate (2.2%).

Earnings vs Market: NUS's earnings (12.9% per year) are forecast to grow slower than the US market (22.1% per year).

High Growth Earnings: NUS's earnings are forecast to grow, but not significantly.

Revenue vs Market: NUS's revenue (5.4% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: NUS's revenue (5.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NUS's Return on Equity is forecast to be high in 3 years time (20%)


Next Steps

Past Performance

How has Nu Skin Enterprises performed over the past 5 years?

-0.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NUS has high quality earnings.

Growing Profit Margin: NUS's current net profit margins (6.3%) are higher than last year (4.8%).


Past Earnings Growth Analysis

Earnings Trend: NUS's earnings have declined by 0.3% per year over the past 5 years.

Accelerating Growth: NUS's earnings growth over the past year (17%) exceeds its 5-year average (-0.3% per year).

Earnings vs Industry: NUS earnings growth over the past year (17%) exceeded the Personal Products industry 7.3%.


Return on Equity

High ROE: NUS's Return on Equity (18.4%) is considered low.


Next Steps

Financial Health

How is Nu Skin Enterprises's financial position?


Financial Position Analysis

Short Term Liabilities: NUS's short term assets ($785.8M) exceed its short term liabilities ($484.6M).

Long Term Liabilities: NUS's short term assets ($785.8M) exceed its long term liabilities ($517.8M).


Debt to Equity History and Analysis

Debt Level: NUS's debt to equity ratio (52.4%) is considered high.

Reducing Debt: NUS's debt to equity ratio has increased from 27.9% to 52.4% over the past 5 years.

Debt Coverage: NUS's debt is well covered by operating cash flow (65%).

Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (11.4x coverage).


Balance Sheet


Next Steps

Dividend

What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?

2.80%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: NUS's dividend (2.8%) is higher than the bottom 25% of dividend payers in the US market (1.63%).

High Dividend: NUS's dividend (2.8%) is low compared to the top 25% of dividend payers in the US market (4.56%).


Stability and Growth of Payments

Stable Dividend: NUS's dividends per share have been stable in the past 10 years.

Growing Dividend: NUS's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (55.7%), NUS's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: NUS's dividends in 3 years are forecast to be well covered by earnings (45.2% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.1yrs

Average management tenure


CEO

Ritch Wood (54 yo)

3.58yrs

Tenure

US$4,570,380

Compensation

Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to Mar ...


CEO Compensation Analysis

Compensation vs Market: Ritch's total compensation ($USD4.57M) is about average for companies of similar size in the US market ($USD5.60M).

Compensation vs Earnings: Ritch's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Steven Lund
Executive Chairman of the Board8.42yrsUS$627.58k0.49%
$ 13.5m
Ritch Wood
CEO & Director3.58yrsUS$4.57m0.39%
$ 10.7m
Ryan Napierski
President3.58yrsUS$2.30m0.16%
$ 4.4m
Mark Lawrence
Executive VP & CFO3.58yrsUS$3.13m0.10%
$ 2.8m
Joseph Chang
Executive VP of Product Development & Chief Scientific Officer14.67yrsUS$1.47m0.15%
$ 4.2m
D. Dorny
Executive VP17.75yrsUS$1.28m0.089%
$ 2.4m
Blake Roney
36.75yrsUS$621.69kno data
Sandra Tillotson
24.75yrsUS$1.06mno data
James Thomas
Chief Accounting Officer1.17yrsno data0.014%
$ 381.5k
Vince Perfetti
Chief Transformation Officer & Senior VP of Technology1.42yrsno datano data
Mark Adams
Chief Information Officer14.67yrsno datano data
Scott Pond
Vice President of Investor Relationsno datano datano data

9.1yrs

Average Tenure

58.5yo

Average Age

Experienced Management: NUS's management team is seasoned and experienced (9.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Lund
Executive Chairman of the Board8.42yrsUS$627.58k0.49%
$ 13.5m
Ritch Wood
CEO & Director3.58yrsUS$4.57m0.39%
$ 10.7m
Edwina Woodbury
Independent Director5.33yrsUS$287.43k0.016%
$ 450.9k
Andrew Lipman
Independent Director21.42yrsUS$306.07k0.14%
$ 3.9m
Daniel Campbell
Lead Independent Directorno dataUS$278.43k0.15%
$ 4.1m
Lars Bohlin
Member of Anti-Aging Scientific Advisory Boardno datano datano data
Thomas Pisano
Independent Director12.33yrsUS$287.43k0.099%
$ 2.7m
Zoe Draelos
Member of the Anti-Aging Scientific Advisory Board10.75yrsno datano data
Paul Cox
Member of Anti-Aging Scientific Advisory Boardno datano datano data
Tomas Prolla
Member of Anti-aging Scientific Advisory Board11yrsno datano data
Zheqing Shen
Independent Director4.25yrsUS$234.60k0.016%
$ 449.3k
Makoto Kuro-O
Member of Anti-Aging Scientific Advisory Boardno datano datano data

9.6yrs

Average Tenure

67yo

Average Age

Experienced Board: NUS's board of directors are considered experienced (9.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: NUS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Nu Skin Enterprises, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nu Skin Enterprises, Inc.
  • Ticker: NUS
  • Exchange: NYSE
  • Founded: 1984
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$2.756b
  • Shares outstanding: 51.39m
  • Website: https://www.nuskin.com

Number of Employees


Location

  • Nu Skin Enterprises, Inc.
  • 75 West Center Street
  • Provo
  • Utah
  • 84601
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NUSNYSE (New York Stock Exchange)YesClass A Common StockUSUSDNov 1996
NUSDB (Deutsche Boerse AG)YesClass A Common StockDEEURNov 1996

Biography

Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/26 23:58
End of Day Share Price2020/10/26 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.